IL96064A - History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them - Google Patents

History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them

Info

Publication number
IL96064A
IL96064A IL9606490A IL9606490A IL96064A IL 96064 A IL96064 A IL 96064A IL 9606490 A IL9606490 A IL 9606490A IL 9606490 A IL9606490 A IL 9606490A IL 96064 A IL96064 A IL 96064A
Authority
IL
Israel
Prior art keywords
represented
benzo
compound according
compounds
integer
Prior art date
Application number
IL9606490A
Other languages
English (en)
Hebrew (he)
Other versions
IL96064A0 (en
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of IL96064A0 publication Critical patent/IL96064A0/xx
Publication of IL96064A publication Critical patent/IL96064A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
IL9606490A 1989-10-20 1990-10-19 History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them IL96064A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42442989A 1989-10-20 1989-10-20

Publications (2)

Publication Number Publication Date
IL96064A0 IL96064A0 (en) 1991-07-18
IL96064A true IL96064A (en) 1994-11-28

Family

ID=23682608

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9606490A IL96064A (en) 1989-10-20 1990-10-19 History of 2-] 1-Paneoxy-2-phenylalkyl [imidazoline and 2, 2, 3, 4-tetrahydro-pyrimidine and medicinal preparations containing them

Country Status (21)

Country Link
EP (1) EP0423802B1 (de)
JP (1) JP3097696B2 (de)
KR (1) KR0182808B1 (de)
CN (1) CN1028099C (de)
AR (1) AR248400A1 (de)
AT (1) ATE126217T1 (de)
AU (1) AU627627B2 (de)
CA (1) CA2027530C (de)
DE (1) DE69021490T2 (de)
DK (1) DK0423802T3 (de)
ES (1) ES2088936T3 (de)
FI (1) FI104717B (de)
GR (1) GR3017775T3 (de)
HU (1) HU207300B (de)
IE (1) IE67049B1 (de)
IL (1) IL96064A (de)
NO (1) NO179367C (de)
NZ (1) NZ235688A (de)
PH (1) PH27290A (de)
PT (1) PT95637B (de)
ZA (1) ZA908234B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100276994B1 (ko) * 1992-02-06 2002-06-20 슈테펜엘.네스비트 아릴알콕시페녹시-이미다졸린화합물
KR100693139B1 (ko) * 2001-04-19 2007-03-13 엘지전자 주식회사 디스크 드라이브의 트레이 진동방지구조
KR100482010B1 (ko) 2002-11-05 2005-04-14 삼성전자주식회사 모니터장치
EP1958507A1 (de) 2007-02-15 2008-08-20 Syngeta Participations AG Chemische Verbindungen
CA2691082A1 (en) * 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE614596C (de) * 1931-07-10 1935-06-13 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von ?-Glyoxalidinarylmethylolen
US2893993A (en) * 1958-06-17 1959-07-07 Searle & Co 2-aryloxyaralkyl-1, 4, 5, 6-tetrahydropyrimidines
US3897431A (en) * 1969-04-24 1975-07-29 Sterling Drug Inc 2-{8 {60 -Alkoxy-arylmethyl{9 -2-imidazolines and -1,4,5,6-tetrahydropyrimidines
NL7804482A (nl) * 1977-04-29 1978-10-31 Ciba Geigy Preparaten ter bestrijding van ectoparasieten.
EP0011596B1 (de) * 1978-10-09 1981-12-30 Ciba-Geigy Ag Neue 2-(alpha-Phenoxy-alkyl)-imidazoline und ihre Salze, deren Herstellung und Verwendung sowie sie enthaltende Mittel zur Bekämpfung von pflanzenschädlichen und tierparasitären Milben
US4260626A (en) * 1979-03-26 1981-04-07 Richardson-Merrell Inc. Tetrahydro and imidazoline antisecretory compounds
IT1231237B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati eterociclici

Also Published As

Publication number Publication date
AU627627B2 (en) 1992-08-27
PT95637B (pt) 1998-04-30
NO179367C (no) 1996-09-25
IE903765A1 (en) 1991-04-24
FI104717B (fi) 2000-03-31
NO904535D0 (no) 1990-10-19
KR910007887A (ko) 1991-05-30
JP3097696B2 (ja) 2000-10-10
DK0423802T3 (da) 1995-09-18
JPH03135960A (ja) 1991-06-10
ES2088936T3 (es) 1996-10-01
KR0182808B1 (ko) 1999-05-01
DE69021490D1 (de) 1995-09-14
PH27290A (en) 1993-05-04
ATE126217T1 (de) 1995-08-15
CN1028099C (zh) 1995-04-05
CA2027530C (en) 2001-05-08
GR3017775T3 (en) 1996-01-31
NO904535L (no) 1991-04-22
HU906514D0 (en) 1991-04-29
PT95637A (pt) 1991-09-13
CA2027530A1 (en) 1991-04-21
AU6456590A (en) 1991-04-26
HUT55366A (en) 1991-05-28
IE67049B1 (en) 1996-02-21
FI905168A0 (fi) 1990-10-19
NO179367B (no) 1996-06-17
ZA908234B (en) 1991-08-28
DE69021490T2 (de) 1996-02-01
EP0423802A1 (de) 1991-04-24
CN1051039A (zh) 1991-05-01
HU207300B (en) 1993-03-29
AR248400A1 (es) 1995-08-18
IL96064A0 (en) 1991-07-18
NZ235688A (en) 1992-02-25
EP0423802B1 (de) 1995-08-09

Similar Documents

Publication Publication Date Title
KR19990029067A (ko) 피페라진 유도체 및 ５­ｈｔ１ａ 길항제로서의 이의용도
CA1111038A (en) Antisecretory compounds
CA1173044A (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
PH26080A (en) Novel antihypertensive benzopyran derivatives
FR2680172A1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
CA1308108C (en) Antihypertensive benzopyran derivatives
FR2756560A1 (fr) Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR100274103B1 (ko) 5,6,-디하이드로나프토[1,2-b]피란 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JPH089615B2 (ja) β―カルボリン―３―カルボン酸誘導体、その製造法及び該化合物を含有する精神安定剤
HU187337B (en) Process for producing sbstituted oxo-carboxylic acids and pharmaceutical compositions containing them
JPH068285B2 (ja) 三環式アミン、その製法及び医薬組成物
FR2642755A1 (de)
EP0423802B1 (de) Phenoxyheterozyklische Verbindungen
US5134154A (en) Phenoxy-heterocyclic compounds
EP1828125B1 (de) Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden
US4806551A (en) N-dihydroindolylethyl-sulphonamides
US4622336A (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives, processes for their production and pharmaceutical compositions comprising them
JPS61100579A (ja) ピリジン誘導体
US4579845A (en) Antihypertensive cyanoguanidines
US3998842A (en) Diazepino[1,2-α]indoles
US3996373A (en) 2,3-Dihydro-1H-dibenz[e,g]isoindole compounds
US5252597A (en) Antihypertensive benzopyran derivatives
US4497818A (en) 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antihypertensives and platelet aggregation inhibitors
CA2195157A1 (en) (1h-indol-4-yl)-piperidine or tetrahydropyridine ethylamines and ethylcarboxamides
EP0668276A1 (de) 2-alkoxy-5,6,7,8-tetrahydrochinoxalin-derivate, verfahren zu deren herstellung und anwendung

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
HP Change in proprietorship
RH Patent void
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INCORPORATED